4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)(2-methoxyphenyl)methyl)-2H-chromen-2-one

ID: ALA265181

Chembl Id: CHEMBL265181

Cas Number: 10172-73-3

PubChem CID: 54686422

Max Phase: Preclinical

Molecular Formula: C26H18O7

Molecular Weight: 442.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1C(c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O

Standard InChI:  InChI=1S/C26H18O7/c1-31-17-11-5-2-8-14(17)20(21-23(27)15-9-3-6-12-18(15)32-25(21)29)22-24(28)16-10-4-7-13-19(16)33-26(22)30/h2-13,20,27-28H,1H3

Standard InChI Key:  AGVFKBGSCZJNOY-UHFFFAOYSA-N

Associated Targets(Human)

HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HuTu80 (255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Urease (750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
4T1 (1737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 442.42Molecular Weight (Monoisotopic): 442.1053AlogP: 4.50#Rotatable Bonds: 4
Polar Surface Area: 110.11Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.91CX Basic pKa: CX LogP: 3.21CX LogD: -0.88
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: 0.04

References

1. Zaheer-ul-Haq, Lodhi MA, Ahmad Nawaz S, Iqbal S, Mohammed Khan K, Rode BM, Atta-ur-Rahman, Choudhary MI..  (2008)  3D-QSAR CoMFA studies on bis-coumarine analogues as urease inhibitors: a strategic design in anti-urease agents.,  16  (6): [PMID:18280742] [10.1016/j.bmc.2005.09.048]
2. Zhou HY, Dong FQ, Du XL, Zhou ZK, Huo HR, Wang WH, Zhan HD, Dai YF, Jing Meng, Sui YP, Li J, Sui F, Zhai YH..  (2016)  Antitumor activities of biscoumarin and dihydropyran derivatives.,  26  (16): [PMID:27432761] [10.1016/j.bmcl.2016.07.023]

Source